Lupin Limited (LUPIN) announces U.S. FDA approval and launch of Sugammadex Injection, a bioequivalent to Bridion®.
Anlon Healthcare Limited (AHCL) reports 163% topline growth, 150% EBITDA growth and 133% PAT growth in Q1 FY27, strengthening its integrated pharmaceutical p.
Mankind Pharma Limited (NSE: MANKIND) drops 5% intraday to ₹2441.0, experiencing profit-taking following a recent breakout..
Indegene Limited (INDGN) reports strong Q1 FY27 performance with 39.7% YoY revenue growth and 45.9% QoQ PAT increase.
Alivus Life Sciences Limited (ALIVUS) reports Q1 FY27 with 32% PAT growth, 25% margins, and revenue up 6.4% YoY.
Global Health Limited (NSE: MEDANTA) reports Q1 FY2027 with highest ever quarterly total income and EBITDA.
Rainbow Childrens Medicare Limited (RAINBOW) reports robust Q1 FY27 performance with 33% YoY revenue growth, expansion plans in Mumbai, and acquisitions in A.
Mankind Pharma Limited (NSE: MANKIND) reports strong Q1FY27 with revenue up 13%, EBITDA growth of 25%, and PAT growth of 29%.
Fischer Medical Ventures Limited (FISCHER) secures CDSCO import approval for Spincare, India's first portable electrospun wound care system.
Hester Biosciences Limited (HESTERBIO) Q1 FY27: Standalone revenue up 14%, profit up 88%; consolidated revenue down 8%, profit up 459%.